RS11062102 Unknown gene
Upload your DNA to see your genotype for this variant.
GWAS Studies (20)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| 1-methyl-4-imidazoleacetate levels | C | OR: 0.49 | 4E-140 | PubMed |
| Metabolite levels (deoxycarnitine; butyrobetaine) | C | OR: 0.35 | 1E-122 | PubMed |
| Deoxycarnitine levels | C | OR: 0.45 | 2E-116 | PubMed |
| Creatinine levels | T | β: 0.027 | 3E-88 | PubMed |
| Metabolite levels (1-methylimidazoleacetate; 1-methyl-4-imidazoleacetate; methylimidazoleacetic acid) | C | OR: 0.31 | 8E-86 | PubMed |
| Serum metabolite levels | T | OR: 0.42 | 2E-67 | PubMed |
| Estimated glomerular filtration rate (creatinine) | C | OR: 16.19 | 6E-59 | PubMed |
| Plasma 1-methyl-4-imidazoleacetate levels in chronic kidney disease | C | OR: 0.18 | 6E-50 | PubMed |
| Estimated glomerular filtration rate (creatinine) | C | β: 0.004 | 8E-49 | PubMed |
| Serum creatinine levels | C | β: 0.024 | 1E-46 | PubMed |
| Estimated glomerular filtration rate (creatinine) | C | β: 0.004 | 4E-36 | PubMed |
| Butyrobetaine levels | C | OR: 0.34 | 3E-31 | PubMed |
| Creatinine levels | C | β: 0.02 | 3E-27 | PubMed |
| creatinine (mean, inv-norm transformed) | T | β: 0.027 | 5E-25 | PubMed |
| estimated glomerular filtration rate (eGFR, mean, inv-norm transformed) | T | β: 0.026 | 7E-24 | PubMed |
| creatinine (minimum, inv-norm transformed) | T | β: 0.026 | 4E-23 | PubMed |
| Guanidinoacetate levels | T | OR: 0.1 | 2E-21 | PubMed |
| Estimated glomerular filtration rate | C | OR: 9.44 | 4E-21 | PubMed |
| estimated glomerular filtration rate (eGFR, maximum, inv-norm transformed) | T | β: 0.024 | 1E-20 | PubMed |
| Bicarbonate (maximum, inv-norm transformed) | T | β: 0.025 | 5E-20 | PubMed |